Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation (Scientific Reports, (2021), 11, 1, (2227), 10.1038/s41598-021-81803-6)

Noam Shohat, Karan Goswami, Leigham Breckenridge, Michael B. Held, Arthur L. Malkani, Roshan P. Shah, Ran Schwarzkopf, Javad Parvizi*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The original version of this Article contained an error in Table 2, where in columns “Total cohort (n = 1212)” and “Fasting plasma glucose ≥ 100 mg/dL (n = 423)”, the n values for ‘Normal fructosamine’ and ‘High fructosamine’ were accidently switched. The correct and incorrect heading rows appear below. Incorrect: (Table presented.) Correct: (Table presented.) The original Article has been corrected.

Original languageEnglish
Article number16026
JournalScientific Reports
Volume11
Issue number1
DOIs
StatePublished - Dec 2021

Fingerprint

Dive into the research topics of 'Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation (Scientific Reports, (2021), 11, 1, (2227), 10.1038/s41598-021-81803-6)'. Together they form a unique fingerprint.

Cite this